Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Revive Therapeutics Ltd (TSE:RVV)
CNQX:RVV
Holding TSE:RVV?
Track your performance easily
RVV Stock Chart & Stats
Day’s RangeC$0 - C$0
52-Week Range<C$0.01 - C$0.04
Previous CloseC$0.01
Volume500.00
Average Volume (3M)403.03K
Market Cap
C$1.79M
Enterprise ValueC$800.35K
Total Cash (Recent Filing)C$1.05M
Total Debt (Recent Filing)C$61.51K
Price to Earnings (P/E)―
Beta1.04
Next Earnings
Oct 28, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.01
Shares Outstanding418,564,269
10 Day Avg. Volume184,985
30 Day Avg. Volume403,030
Standard Deviation0.36
R-Squared0.00097
Alpha0.03
Financial Highlights & Ratios
Price to Book (P/B)0.25
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-0.30
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Revive Therapeutics News
PremiumCompany Announcements
Revive Therapeutics Prioritizes Bucillamine Development
PremiumCompany Announcements
Revive Therapeutics Explores Bucillamine for Nerve Agents and Viral Threats
PremiumCompany Announcements
Revive Therapeutics Tests Treatment for Nerve Agents
PremiumCompany Announcements
Revive Therapeutics Advances Long COVID TreatmentOptions Prices
Currently, No data available
---
Ownership Overview
1.03% Insiders
<0.01% Other Institutional Investors
98.96% Public Companies and
Individual Investors
RVV FAQ
What was Revive Therapeutics Ltd’s price range in the past 12 months?
Revive Therapeutics Ltd lowest stock price was <C$0.01 and its highest was C$0.04 in the past 12 months.
What is Revive Therapeutics Ltd’s market cap?
Currently, no data Available
When is Revive Therapeutics Ltd’s upcoming earnings report date?
Revive Therapeutics Ltd’s upcoming earnings report date is Oct 28, 2024 which is 8 days ago.
How were Revive Therapeutics Ltd’s earnings last quarter?
Revive Therapeutics Ltd released its earnings results on May 30, 2024. The company reported -C$0.005 earnings per share for the quarter, missing the consensus estimate of N/A by -C$0.005.
Is Revive Therapeutics Ltd overvalued?
According to Wall Street analysts Revive Therapeutics Ltd’s price is currently Overvalued.
Does Revive Therapeutics Ltd pay dividends?
Revive Therapeutics Ltd does not currently pay dividends.
What is Revive Therapeutics Ltd’s EPS estimate?
Revive Therapeutics Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Revive Therapeutics Ltd have?
Revive Therapeutics Ltd has 357,646,850 shares outstanding.
What happened to Revive Therapeutics Ltd’s price movement after its last earnings report?
Revive Therapeutics Ltd reported an EPS of -C$0.005 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Revive Therapeutics Ltd?
Currently, no hedge funds are holding shares in TSE:RVV
---
Company Description
Revive Therapeutics Ltd
Revive Therapeutics Ltd is focused on the research, development, and commercialization of novel psychedelic and cannabinoid-based life sciences products and drug repurposing for infectious diseases. The firm's technology is being developed to fill the medical needs for diseases and disorders such as pain, inflammation, and wound care.
---
Technical Analysis
---